FDA Approves Peginterferon Alfa-2b for Melanoma - Skin & Allergy News
Links shared publicly online about this topic.
- 353total visits
FDA Approves Peginterferon Alfa-2b for Melanoma - Skin & Allergy News
View full resource at skinandallergynews.com
Tags: Allergies, Dermatology, Skin, Cancer, Skin Cancer, Melanoma, FDA, News
Most Recently Shared on April 19, 2011 at 9:28 pm By:
FDA Approves Peginterferon Alfa-2b for Melanoma - Skin & Allergy News http://t.co/tLWqK4B via @AddThis
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
drugs.com — “Sylatron (peginterferon alfa-2b) is used for the adjuvant treatment of melanoma. Includes Sylatron side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 14, 2011 at 12:11 am By:
Drugs and Devices OW OW Health
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma... http://bit.ly/fpTNTP #drug
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
drugs.com — “Sylatron (peginterferon alfa-2b) is used for the adjuvant treatment of melanoma. Includes Sylatron side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2011 at 11:43 pm By:
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for the Adjuvant Treatment of Melanoma - http://bit.ly/f4t9Dr
FDA Approves Peginterferon Alfa-2b for Melanoma : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on April 13, 2011 at 9:44 pm By:
Bob Finn - Medical News Net Health News
For node+ melanoma, FDA approves peginterferon alfa-2b, 1st adjuvant therapy approved in >15 yrs. @aliciaault reports. http://bit.ly/fzGy1r
Sylatron Approved as Adjuvant Treatment of Melanoma - MPR
empr.com — “Merck announced that Sylatron (peginterferon alfa-2b injection) has been approved for the adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection, including complete lymphadenectomy.” View full resource at empr.com
Most Recently Shared on April 12, 2011 at 6:53 pm By:
MPR News: Sylatron Approved as Adjuvant Treatment of Melanoma: Merck announced that Sylatron (peginterferon alfa... http://bit.ly/gSUxAo
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 12, 2011 at 1:33 pm By:
eyeonfda Pharma and Health Lawyer
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, Adjuvant Treatment for Melanoma - http://ow.ly/4yq3k
GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
genengnews.com — “GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement” View full resource at genengnews.com
Most Recently Shared on April 12, 2011 at 11:43 am By:
Dr. Anthony Blash PharmD, Doctor, and Pharmacist
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment fo... http://bit.ly/gr7yUC (via @news360app)
FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma
medicalnewstoday.com — “In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ASCO will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safe” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2011 at 9:05 am By:
FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma http://mnt.to/3T34 #skincancer #melanoma
ODAC recommends approval of melanoma drug, renal cell carcinoma drug | HemOncToday
hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee voted 6-4 in favor of pegylated interferon alfa-2b for the adjuvant treatment of stage III mal” View full resource at hemonctoday.com
Most Recently Shared on October 7, 2009 at 1:19 pm By:
RT @mkgraziani: FDA comm. recommends approval of 2 drugs for cancer http://bit.ly/IssKQ
Medical News: Panel Votes Tepid Support for Cancer Adjuvant - in Hematology/Oncology, Lymphoma from MedPage Today
medpagetoday.com — “WASHINGTON -- A cancer advisory committee voted narrowly to support FDA approval of peginterferon alfa-2b (Pegintron) injections as a supplemental therapy for patients with stage III malignant melanom” View full resource at medpagetoday.com
Most Recently Shared on October 5, 2009 at 10:36 pm By:
Panel Votes Tepid Support for Cancer Adjuvant http://bit.ly/kunfe
Peg-Intron/Rebetol combination therapy gains expanded indication - MPR
empr.com — “The FDA has approved new labeling for Schering-Plough's Peg-Intron (peginterferon alfa-2b) and Rebetol (Ribavirin) combination therapy for treating chronic hepatitis C with compensated liver disease in patients 3 years of age.” View full resource at empr.com
Most Recently Shared on March 12, 2009 at 12:22 am By:
Peg-Intron/Rebetol combination therapy gains expanded indication: The FDA has approved new labeling for Schering.. http://tinyurl.com/b56rkd
Advertisement
